Recently, in a German multicenter randomized controlled trial (efficacy of fluid substitution and insulin therapy in severe sepsis (VISEP) study), it was shown that the use of 10% HES 200/0.5 compared with lactated Ringer's solution (RL) in patients with severe sepsis or septic shock is associated with an increased need for renal replacement therapy. This evidence concerns the gene INS and septic shock.